Drug comparisons
Troglitazone vs Dulaglutide
Troglitazone vs Dulaglutide: Withdrawn TZD vs modern GLP-1 agonist Trulicity for type 2 diabetes. Compare safety, mechanisms, and why one is preferred.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered when evaluating historical PPAR-gamma agonists against current GLP-1 receptor agonists for type 2 diabetes treatment options.
Bottom line
Dulaglutide is the preferred modern agent as Troglitazone is no longer available due to severe liver toxicity risks.
All medication comparisons